SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, today announced performance results for ...
Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...
Multiply Labs collaborated with these life science industry leaders to demonstrate automated cell therapy manufacturing tasks, with an emphasis on cell expansion. The results of the proof-of-concept ...
Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...
Researchers at Johns Hopkins, writing in the journal Cell, have found that a single brain stem cell can produce two stem cells just like itself. "If we can somehow cash in on this newly discovered ...
Multiply Labs, a robotics firm, and Retro Biosciences, which is developing therapies to address age-related diseases, signed an agreement valued at up to $85 million to automate Retro’s approach to ...
“Historically, cell and gene therapy manufacturing has been manual, almost artisanal," says Fred Parietti, CEO of Multiply Labs. "Expert scientists perform hundreds of tasks by hand, from pipetting to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results